Loading...
Unity Software Inc (U) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is currently in a bearish technical trend, with weak financial performance and mixed analyst sentiment. While there are some positive catalysts, such as hedge fund buying and Vector's growth, the weak Q1 guidance, declining EPS, and lack of strong proprietary trading signals suggest that waiting for clearer signs of recovery or stability would be prudent.
The technical indicators for Unity Software Inc show a bearish trend. The MACD is negative and expanding downward (-1.185), the RSI is neutral at 22.258, and the stock is trading below key moving averages (SMA_200 > SMA_20 > SMA_5). The key support level is at 20.087, which the stock is hovering near, while resistance levels are far above the current price, indicating limited immediate upside potential.

Hedge funds are significantly increasing their positions in Unity, with a 183.89% increase in buying over the last quarter.
Vector revenue has grown by 53% since its launch, showing strong momentum in this segment.
Unity's Q4 revenue of $503 million exceeded estimates, reflecting solid performance in some areas.
Weak Q1 guidance, with revenue expected between $480-$490 million, below consensus estimates.
Declining EPS (-30% YoY) and net income (-26.70% YoY) in Q4 2025, indicating financial struggles.
Analysts have broadly lowered their price targets, with significant reductions from major firms like Goldman Sachs, UBS, and Morgan Stanley.
Bearish technical indicators and a lack of strong proprietary trading signals.
In Q4 2025, Unity's revenue increased by 10.06% YoY to $503 million. However, net income dropped by 26.70% YoY to -$89.96 million, and EPS declined by 30% YoY to -0.21. Gross margin also slightly decreased to 74.51%. While revenue growth is positive, the overall financial performance is weak, with declining profitability and margins.
Analysts have mixed views on Unity. While some maintain Buy or Overweight ratings (e.g., Wells Fargo, Citi, Morgan Stanley), others have downgraded their price targets significantly. The consensus reflects concerns over weak Q1 guidance, challenges in the Grow segment, and the need for improved R&D investment. Price targets range from $26 to $43, with a median around $30, which is still above the current price but reflects tempered expectations.